SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Sick Visit — Higuchi Ichiyō — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientHiguchi Ichiyō
Date of birth1872-05-02
IdentifiersMRN HR-NI029-SYN-TD; SSN (made up) 000-29-5108
Document date1896-07-20
AuthorAiko Lindgren-Tanaka, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Burning on passing urine for two days. [S]

History of Present Illness

Ms. Higuchi called this morning and was seen the same day. For two days she has had burning when she passes urine, needing to go often and urgently, and a dull ache low in her abdomen. She has no fever, chills, back or flank pain, nausea or vomiting, and no vaginal discharge or itching. She has never had a urinary infection before. She has not been sexually active and is not pregnant. She admits she has been drinking little while writing for long stretches at her desk on hot days. She is in the fourteenth week of tuberculosis treatment, in the continuation phase on isoniazid and rifampin, and has taken every dose on video with the public health center; her urine is orange from rifampin, as expected. Her cough has gone and she is gaining weight. [S]

ElementDetail
OnsetTwo days ago
SymptomsBurning, frequency, urgency and lower abdominal ache
SeverityModerate; no fever
ContextContinuation phase of tuberculosis treatment on isoniazid and rifampin; drinking little
Associated signs and symptomsNo flank pain, fever, vomiting or vaginal discharge

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever, chills or night sweats
GenitourinaryPositiveDysuria, frequency and urgency for two days; urine orange from rifampin; no visible blood
GastrointestinalPositiveDull suprapubic ache; no nausea, vomiting or abdominal pain elsewhere
RespiratoryNegativeNo cough or sputum
MusculoskeletalNegativeNo back or flank pain

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Isoniazid 100 mg tablets, two tablets (200 mg) daily200 mg once daily, observed by video each day through the public health center's directly observed treatment program, for 26 weeksOral route1896-04-17 to 1896-10-15completedS
Rifampin (rifampicin) 150 mg capsules, three capsules (450 mg) daily450 mg once daily on an empty stomach, observed by video each day through the public health center's directly observed treatment program, for 26 weeksOral route1896-04-17 to 1896-10-15completedS
Pyrazinamide 500 mg tablets, two tablets (1000 mg) daily1000 mg once daily, observed by video each day through the public health center's directly observed treatment program, for the eight-week intensive phaseOral route1896-04-17 to 1896-06-11completedS
Ethambutol 100 mg tablets, six tablets (600 mg) daily600 mg once daily, observed by video each day through the public health center's directly observed treatment program, until susceptibility results returnOral route1896-04-17 to 1896-05-22stoppedS
Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily50 mg once daily with isoniazidOral route1896-04-17 to 1896-10-15completedS
Nitrofurantoin monohydrate/macrocrystals 100 mg oral capsule, one capsule twice daily with food for five daysOne capsule twice daily with food for five daysOral route1896-07-20 to 1896-07-24completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1896-07-20Body height148cmS
1896-07-20Body weight42kgS
1896-07-20Body mass index (BMI) [Ratio]19.2kg/m2S
1896-07-20Systolic blood pressure104mm[Hg]S
1896-07-20Diastolic blood pressure66mm[Hg]S
1896-07-20Heart rate84/minS
1896-07-20Respiratory rate16/minS
1896-07-20Body temperature37CelS
1896-07-20Oxygen saturation in Arterial blood by Pulse oximetry98%S

Physical Exam

Vital signs recorded on 1896-07-20; see the Vital Signs section. [S]

SystemFinding
GeneralComfortable; temperature 37.0 °C, pulse 84, blood pressure 104/66; weight 42.0 kg
AbdomenMild suprapubic tenderness; soft; liver not enlarged or tender
BackNo costovertebral angle tenderness
EyesNo icterus
SkinNo rash

Problems

ProblemClinical statusVerificationCodeProvenance
Cough for about seven weeks with evening fevers, night sweats, poor appetite and weight loss of about 4 kg (about 10 percent) in a woman of 23; chest X-ray with patchy right upper lobe opacities and no cavity; suspected pulmonary tuberculosis; airborne precautions and three sputum specimens for acid-fast smear, nucleic acid amplification and cultureresolvedconfirmed R05.3S — Synthetic presenting problem at intake, superseded by the diagnosis at the second visit; its timing echoes her documented decline from early 1896 (D).
Pulmonary tuberculosis of the right upper lobe, sputum smear-negative, confirmed by Xpert MTB/RIF Ultra (Mycobacterium tuberculosis detected, low; rifampin resistance not detected)activeconfirmed A15.0S — Synthetic modern coding of her documented tuberculosis; all bacteriology and imaging are synthetic.
Moderate protein-calorie malnutrition: BMI 17.6, about 10 percent weight loss in two months, and albumin 3.3 g/dLactiveconfirmed E44.0S — Synthetic nutrition diagnosis at intake, anchored to her documented poverty.
Low and irregular income from writing, with a household to support; costs of care are a barrieractiveconfirmed Z59.6S — Synthetic social need anchored to her documented poverty and household responsibilities.
Acute uncomplicated cystitis, treated with nitrofurantoin rather than a fluoroquinolone during tuberculosis treatment; resolvedactiveconfirmed N30.00S — Synthetic intercurrent illness; not a historical claim.

Assessment and Plan

Guideline basis: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases (2010)

Follow-up: Culture result by phone. Preventive visit in five weeks as booked. Return sooner for fever or flank pain. Next scheduled visit 1896-08-24: periodic adult preventive visit. [S]